Compared with the control group, RASSF6-stably expressed cells revealed a decreased tumor size and tumor weight, whereas low RASSF6 level in HT-29 promoted tumor growth as compared to control siRNA group (Figure 3G and 3H). Here, RASSF6 is linked to neoplasm.